Brunel Institute of Cancer Genetics and Pharmacogenomics;
Division of Biosciences;
School of Health Sciences and Social Care;
Brunel University;
Uxbridge;
UK;
Department of Radiotherapy;
St Bartholomew’s Hospital;
West Smithfield;
London;
UK;
BRCA1; BRCA2; Heterozygote; Radiosensitivity; PARP; Inhibitor; Gamma-H2AX; Imaging; Flow; Cytometry;